0000886163-15-000030.txt : 20150225 0000886163-15-000030.hdr.sgml : 20150225 20150225180018 ACCESSION NUMBER: 0000886163-15-000030 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150225 DATE AS OF CHANGE: 20150225 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Herman Melanie J CENTRAL INDEX KEY: 0001605325 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 15649202 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 4/A 1 edgardoc.xml PRIMARY DOCUMENT X0306 4/A 2014-12-31 2015-01-05 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001605325 Herman Melanie J 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 0 1 0 0 Director of Accounting Common Stock 2014-12-31 2014-12-31 4 J 0 103.0 45.2285 A 2831 D Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c). The Amount of Securities Beneficially Owned is reflected as of the original filing date. By: Charles S. Berkman For: Melanie J. Herman 2015-02-25